Expression of pituitary-tumour transforming gene in colorectal tumours

Lancet

Volumn 355, Issue 9205, 2000, Pages 716-719

  Heaney, Anthony P ^a   Singson, Regina ^a   McCabe, Chris J ^a   Nelson, Viera ^a   Nakashima, Masahiro ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; TUMOR MARKER;

ANGIOGENESIS; ARTICLE; CANCER INVASION; COLON POLYP; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTESTINE WALL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOGENESIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0034716480     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)10238-1     Document Type: Article

References (30)

1. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
2. Fearon E.R., Cho K.R., Nigro J.M.et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:1990;49-56.
3. Baker S.J., Fearon E.R., Nigro J.M.et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221.
4. Boss J.L., Fearon E.R., Hamilton S.R.et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 327:1987;293-297.
5. Forrester K., Almoguera C., Han K., Grizzle W.E., Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature. 327:1987;298-303.
6. Vogelstein B., Fearon E.R., Hamilton S.R.et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532.
7. D'Emilia J., Bulovas K., D'Erole K., Wolf B., Steele G., Summerhayes I.C. Expression of the c-erbB-2 gene product (P185) at different stages of neoplastic progression in the colon. Oncogene. 4:1989;1233-1239.
8. Finley G.C., Schultz N.T., Hill S.A., Geiser J.R., Pipas J.M., Meisler A.I. Expression of the myc gene family in different stages of human colorectal cancer. Oncogene. 4:1989;963-971.
9. Pei L., Melmed S. Isolation and characterization of a Pituitary Tumor-Transforming Gene (PTTG). Mol Endocrinol. 11:1997;433-441.
10. Zhang X., Horwitz G.A., Prezant T.P.et al. Structure, expression and function of human pituitary transforming gene (PTTG). Mol Endocrinol. 13:1999;156-166.
11. Zou H., McGarry T.J., Bernal T., Kirschner M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 285:1999;418-422.
12. 1) and fibroblast growth factor (bFGF) expression in prolactinoma pathogenesis. Nat Med. 5:1999;1317-1321.
13. Zhang X., Horowitz G.A., Heaney A.P.et al. Pituitary tumor transforming gene expression in human pituitary adenomas. J Clin Endocrinol Metab. 84:1999;761-767.
14. Prezant T.P., Kadioglu P., Melmed S. An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. J Clin Endocrinol Metab. 84:1999;1149-1152.
15. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 3:1992;65-71.
16. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr Rev. 18:1997;26-45.
17. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 18:1997;4-25.
18. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 141:1998;1659-1673.
19. Wilkinson M.C., Gardner M.J., Gould P.W., Taylor B.A., Fernig D.G. Normal and malignant human colonic mucosa contain acidic and basic fibroblast growth factors. Int J Oncol. 3:1993;933-936.
20. Jayson G.C., Evans G.S., Pemberton P.W., Lobley R.W., Allen T. Basic fibroblast growth factor increases the multiplication and migration of a serum-free derivative of CACO-2 but does not affect differentiation. Cancer Res. 54:1994;5718-5723.
21. Nakata S., Ito K.-I., Fujimori M.et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int J Cancer. 79:1998;179-186.
22. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasia-correlation in invasive breast carcinoma. N Engl J Med. 324:1992;1-8.
23. Bosari S., Lee A.K.C., DeLellis R.A., Wiley B.D., Heatley G.J., Silverman M.L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 23:1998;755-761.
24. Guldi A.J., Fischer L., Harris J.R., Schnitt S.J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst. 86:1994;614-619.
25. Graham C.H., Rivers J., Kerbel R.S., Stankiewicz K.S., White W.L. Extent of vascularization as a prognostic indicator in thin (<0·76 mm) malignant melanomas. Am J Pathol. 145:1994;510-514.
26. Murgue B., Tsunekawa S., Rosenberg I., De Beaumont M., Podolsky D.K. Identification of a novel variant form fibroblast growth factor receptor 3 (FGFR3 III) in human epithelium. Cancer Res. 54:1994;5206-5211.
27. Galzie Z., Fernig D.F., Smith J.A., Poston G.J., Kinsella A.R. Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor. Int J Cancer. 71:1997;390-395.
28. Nowell P.C. The clonal evolution of tumor cell populations: acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science. 194:1976;23-28.
29. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
30. Orr-Weaver T.L. The difficulty in separating sisters. Science. 285:1999;344-345.